John Oliver, a quality assurance specialist at SPS, presents a summary of the resources published by SPS between 6th and 12th September. To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter. Quick links to highlighted resources:     Ensuring time critical use of rasburicase Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy. https://www.sps.nhs.uk/articles/ensuring-time-critical-use-of-rasburicase/ Preparing to use denosumab 60mg biosimilar Biosimilars of denosumab 60mg (Prolia) are expected soon. We offer general information and implementation advice. https://www.sps.nhs.uk/articles/preparing-to-use-denosumab-60mg-biosimilar-for-osteoporosis/ Understanding biosimilar and generic market entry – explainer video New medicines have several protections against competition. Other factors influence availability of biosimilars or generics after loss of exclusivity. https://www.sps.nhs.uk/articles/understanding-biosimilar-and-generic-market-entry/ SPS Vacancies: Senior Specialist Pharmacist Medicines Advice & Medicines Use and Safety (closing date 24 September) https://www.jobs.nhs.uk/candidate/jobadvert/C9287-25-1466?keyword=pharmacist&location=Liverpool&distance=5&language=en&page=2 Senior Specialist Pharmacist, Medicines Use and Safety (closing date 24 September) https://www.jobs.nhs.uk/candidate/jobadvert/C9287-25-1470 Next events – forthcoming webinars and conferences https://www.sps.nhs.uk/home/events/next-events/     Podcast description:    NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.